Post-marketing requirement study to evaluate the safety of Octaplas™ versus plasma in patients undergoing orthotopic liver transplantation with special emphasis on hyperfibrinolysis,
Role: Investigator,
Octapharma,
(06/2018 - 06/2019)
Status: Completed